Compared with normal breast samples, the majority of breast cancer lesions displayed significantly higher Gpr132 expression (Figure 4B); in addition, compared with ER-positive breast cancers, the more aggressive ER-negative breast cancers also exhibited higher Gpr132 expression (Figure 4C). The gene discussed is GPR132; the disease is breast cancer.